InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by Helsel Dave, Vice-Président Senior, Opérations Globales et R&D. Officer active across 1 companies, notably Angiodynamics INC. In total, 9 disclosures have been published. Total volume traded: €243k. The latest transaction was filed on 28 April 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€75,0483,513 shares@ €21.36290.017% mcap27.7% of flow
Common Stock
SEC:0001567619-22-009209:0·
€83,8503,494 shares@ €23.99830.019% mcap85.4% of flow
Common Stock
SEC:0001567619-21-018544·
€83,8503,494 shares@ €23.99830.019% mcap30.9% of flow
Common Stock
SEC:0001567619-21-018544:0·
011,406 shares0
Common Stock
SEC:0001567619-21-016019·
011,406 shares0
Common Stock
SEC:0001567619-21-016019:0·
02,685 shares0
Common Stock
SEC:0001567619-21-015952·
02,685 shares0
Common Stock
SEC:0001567619-21-015952:0·
€14,295640 shares@ €22.33520.0032% mcap14.6% of flow
Common Stock
SEC:0001567619-21-013925·
€14,295640 shares@ €22.33520.0032% mcap5.3% of flow
Common Stock
SEC:0001567619-21-013925:0·
9 of 9 declarations
About Helsel Dave
Dave Helsel is the Senior Vice President of Global Operations and R&D at AngioDynamics Inc. He plays a key role in optimizing operations and product innovation, ensuring that the company remains at the forefront of medical technologies. His expertise in operational management is crucial for the company's success.
